This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Les Laboratoires Servier. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Marc Konnert: Innovator in Medicinal Chemistry
Introduction
Marc Konnert is a notable inventor based in Deuil-la-Barre, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on isoquinoline compounds. His research focuses on developing pharmaceutical compositions that can effectively treat various pathologies.
Latest Patents
Marc Konnert holds a patent for isoquinoline compounds, which includes a process for their preparation and pharmaceutical compositions containing them. The patent describes a compound of formula (I), wherein the substituents are defined in the description. These medicinal products are particularly useful in treating or preventing conditions resulting from the activation of the RhoA/ROCK pathway and the phosphorylation of the myosin light chain.
Career Highlights
Konnert is associated with Les Laboratoires Servier, a prominent pharmaceutical company. His work at Servier has allowed him to focus on the development of innovative therapeutic solutions. His dedication to research and development has positioned him as a key figure in the field of medicinal chemistry.
Collaborations
Throughout his career, Marc Konnert has collaborated with talented professionals, including Stéfano Chimenti and Christine Courchay. These collaborations have enhanced his research efforts and contributed to the advancement of pharmaceutical sciences.
Conclusion
Marc Konnert's contributions to medicinal chemistry, particularly through his patent on isoquinoline compounds, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for new therapeutic options in treating complex medical conditions.